Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04400461
Other study ID # 165/20
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 15, 2020
Est. completion date March 1, 2021

Study information

Verified date April 2021
Source Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Little is known about the physical function outcomes in patients with severe COVID-19 patients who are admitted to Intensive Care Unit (ICU) for invasive mechanical ventilation. The purpose of this study is to evaluate the short-term impact on physical function before hospital discharge in subjects with severe COVID-19 who have survived ICU admission for invasive mechanical ventilation.


Description:

DESIGN: An observation cohort study conducted in a tertiary hospital. METHODS: Data will be collected from patients along the ICU-hospital discharge continuum, will be analysed and non-parametric tests will be used to explore association between variables. Outcome measures: Muscle strength, as a component of physical function, will be evaluated with the Medical Research Council sum score (MRC- SS) at discharge from ICU and at hospital discharge; the Functional Status Score for the ICU (FSS-ICU) will also be assessed at hospital discharge. Data on participants' demographics, ICU admission and hospital admission will also be collected. SIGNIFICANCE OF THE RESEARCH: Understanding how physical function is affected in patients with severe COVID-19 may help develop future prevention, therapeutic and follow-up strategies that improve quality of care and outcomes in this specific group of patients. Findings from this study may be useful to design future larger cohort studies and experimental trials.


Recruitment information / eligibility

Status Completed
Enrollment 71
Est. completion date March 1, 2021
Est. primary completion date February 25, 2021
Accepts healthy volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - subjects diagnosed with COVID-19 who have required admission to ICU for invasive mechanical ventilation; - have received invasive ventilation > 24 hours; - have been successfully weaned from mechanical ventilation > 48 hours; - were independently able to mobilise prior to current hospital admission (this includes subjects who used a walking stick or another gait aid to mobilise. Exclusion Criteria: - subjects or proxies with inability to communicate in Spanish fluently; - cognitive impairment prior to ICU admission; - proven neurological impairment or neuromuscular disorder; - Cerebrovascular Accident during hospital stay; - previous organ transplant; - pregnancy; - unstable fractures or any other injuries that would require medical bed rest.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Data collection and clinical testing of subjects
Clinical Testing: muscle strength. Muscle strength, as a component of physical function, will be assessed with the Medical Research Council sum score (MRC- SS) at discharge from the ICU and at discharge from the hospital. Clinical testing: physical function. The Functional Status Score for the ICU (FSS-ICU) will be used to evaluate 5 functional tasks at discharge from hospital.

Locations

Country Name City State
Spain Medical ICU. Hospital Universitario Ramón y Cajal Madrid
Spain Surgical ICU. Hospital Universitario Ramón y Cajal Madrid

Sponsors (1)

Lead Sponsor Collaborator
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Medical Research Council sum score (MRC- SS). Physical examination will be performed to carry out manual muscle testing of strength in 6 different muscle groups of the upper limb and lower limb on both sides of the body. < 48 hours before ICU discharge
Primary Medical Research Council sum score (MRC- SS). Physical examination will be performed to carry out manual muscle testing of strength in 6 different muscle groups of the upper limb and lower limb on both sides of the body. < 24 hours before hospital discharge
Primary The Functional Status Score for the ICU (FSS-ICU) The Functional Status Score for the ICU (FSS-ICU) will be used to evaluate 5 functional tasks. Each task is evaluated using an 8-point ordinal scale ranging from 0 (not able to perform) to 7 (complete independence).The total FSS-ICU score ranges from 0 to 35, with higher scores indicating better physical functioning. < 24 hours before hospital discharge
Secondary Age Age in years Through study completion, up to 6 months
Secondary Sex Male vs Female Throughout study completion , up to 6 month
Secondary Body Mass Index kg/m2 Throughout study completion, up to 6 months
Secondary Baseline mobility Baseline mobility First day the patient can cooperate with assessment according to the ' 5 Standard Questions' test.
Secondary APACHE II score Acute Physiology and Chronic Health Evaluation II score.The APACHE II score ranges from 0 to 71 points. Higher scores correspond to more severe disease and a higher risk of death. <24 hours after ICU admission
Secondary Length of stay in ICU Number of days of stay in ICU Throughout the study completion, up to 6 months
Secondary Number of days on mechanical ventilation Number of days on mechanical ventilation Throughout the study completion, up to 6 months
Secondary Polyneuropathy diagnosis Clinical or EMG polyneuropathy diagnosis confirmation Throughout the study completion, up to 6 months
Secondary Number of days on Neuromuscular Blockers Number of days on NMB during mechanical ventilation Throughout the study completion, up to 6 months
Secondary Episodes of prone positioning Number of prone positioning episodes during ICU stay Throughout the study completion, up to 6 months
Secondary Length of stay in hospital Total number of days admitted to hospital Throughout the study completion, up to 6 months
Secondary Continuation of care Home with no follow-up physiotherapy, home with domiciliary or out-patient physiotherapy, rehabilitation facility, care home, transfer to another acute hospital. Throughout the study completion, up to 6 months
See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure